Bleeding and management of coagulopathy

Journal of Thoracic and Cardiovascular Surgery

Volumn 142, Issue 3, 2011, Pages 662-667

  Sniecinski, Roman M ^a   Levy, Jerrold H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; BERIPLEX; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 9 COMPLEX; CROSSEAL; CU 2010; DESMOPRESSIN; EVITHROM; FIBRIN GLUE; FIBRINOGEN; FLOSEAL; FRESH FROZEN PLASMA; GELFOAM; HEMOSTATIC AGENT; HYALURONIC ACID; LYSINE; OCTAPLEX; OXIDIZED CELLULOSE; OXIDIZED REGENERATED CELLULOSE; PLACEBO; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SERINE PROTEINASE INHIBITOR; THROMBIN; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ALGORITHM; ANAPHYLAXIS; AORTA SURGERY; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; DRUG EFFICACY; DRUG MEGADOSE; ERYTHROCYTE; FIBRINOLYSIS; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HUMAN; HYPOTENSION; LABORATORY TEST; LENGTH OF STAY; MORTALITY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; THROMBOCYTE; THROMBOCYTE DYSFUNCTION; THROMBOELASTOGRAPHY; THROMBOELASTOMETRY; TRANSFUSION; VASOCONSTRICTION;

EID: 80051788782     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.03.015     Document Type: Article

References (38)

1. O.V. Hein, J. Birnbaum, K.D. Wernecke, W. Konertz, U. Jain, and C. Spies Three-year survival after four major post-cardiac operative complications Crit Care Med 34 2006 2729 2737 (Pubitemid 44610937)
2. M.J. Moulton, L.L. Creswell, M.E. Mackey, J.L. Cox, and M. Rosenbloom Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations J Thorac Cardiovasc Surg 111 1996 1037 1046 (Pubitemid 26146058)
3. M.C. Christensen, S. Krapf, A. Kempel, and C. von Heymann Costs of excessive postoperative hemorrhage in cardiac surgery J Thorac Cardiovasc Surg 138 2009 687 693
4. D. Stainsby, S. MacLennan, D. Thomas, J. Isaac, and P.J. Hamilton Guidelines on the management of massive blood loss Br J Haematol 135 2006 634 641 (Pubitemid 44674073)
5. M.E. Steiner, and G.J. Despotis Transfusion algorithms and how they apply to blood conservation: the high-risk cardiac surgical patient Hematol Oncol Clin North Am 21 2007 177 184 (Pubitemid 46156985)
6. V.A. Ferraris, S.P. Ferraris, and S.P. Saha Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline Ann Thorac Surg 83 2007 S27 S86
7. C.J. Dente, B.H. Shaz, and J.M. Nicholas Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center J Trauma 66 2009 1616 1624
8. J.B. Holcomb, C.E. Wade, and J.E. Michalek Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients Ann Surg 248 2008 447 458
9. M. Levi, M.E. Cromheecke, and E. de Jonge Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints Lancet 354 1999 1940 1947
10. K. Martin, G. Wiesner, T. Breuer, R. Lange, and P. Tassani The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients Anesth Analg 107 2008 1783 1790
11. A. Sedrakyan, A. Wu, G. Sedrakyan, M. Diener-West, M. Tranquilli, and J. Elefteriades Aprotinin use in thoracic aortic surgery: safety and outcomes J Thorac Cardiovasc Surg 132 2006 909 917 (Pubitemid 44415897)
12. D.T. Mangano, I.C. Tudor, and C. Dietzel The risk associated with aprotinin in cardiac surgery N Engl J Med 354 2006 353 365 (Pubitemid 43145060)
13. D.A. Fergusson, P.C. Hebert, and C.D. Mazer A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331 (Pubitemid 351749156)
14. K. Karkouti, D.N. Wijeysundera, T.M. Yau, S.A. McCluskey, G. Tait, and W.S. Beattie The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery Anesth Analg 110 2010 21 29
15. G. Szabo, G. Veres, and T. Radovits The novel synthetic serine protease inhibitor CU-2010 dose-dependently reduces postoperative blood loss and improves postischemic recovery after cardiac surgery in a canine model J Thorac Cardiovasc Surg 139 2010 732 740
16. J.H. Levy, and N.F. Adkinson Jr. Anaphylaxis during cardiac surgery: implications for clinicians Anesth Analg 106 2008 392 403 (Pubitemid 351156659)
17. T. Mochizuki, P.J. Olson, F. Szlam, J.G. Ramsay, and J.H. Levy Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass Anesth Analg 87 1998 781 785 (Pubitemid 28455470)
18. G.J. Despotis, J.H. Joist, and C.W. Hogue Jr. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation J Thorac Cardiovasc Surg 110 1995 46 54
19. A.H. Kuitunen, M.T. Salmenpera, J. Heinonen, V.P. Rasi, and G. Myllyla Heparin rebound: a comparative study of protamine chloride and protamine sulfate in patients undergoing coronary artery bypass surgery J Cardiothorac Vasc Anesth 5 1991 221 226
20. J.H. Levy, J.R. Zaidan, and B. Faraj Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes Anesth Analg 65 1986 739 742 (Pubitemid 16085789)
21. J.H. Levy, I.M. Schwieger, J.R. Zaidan, B.A. Faraj, and W.S. Weintraub Evaluation of patients at risk for protamine reactions J Thorac Cardiovasc Surg 98 1989 200 204 (Pubitemid 19198523)
22. D. de Prost, G. Barbier-Boehm, and J. Hazebroucq Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass Thromb Haemost 68 1992 106 110
23. P.M. Mannucci, and M. Levi Prevention and treatment of major blood loss N Engl J Med 356 2007 2301 2311 (Pubitemid 46849160)
24. M. Blome, F. Isgro, and A.H. Kiessling Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery Thromb Haemost 93 2005 1101 1107 (Pubitemid 40823515)
25. B. Charbit, L. Mandelbrot, and E. Samain The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage J Thromb Haemost 5 2007 266 273 (Pubitemid 46139450)
26. M. Karlsson, L. Ternstrom, M. Hyllner, F. Baghaei, S. Nilsson, and A. Jeppsson Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study Transfusion 48 2008 2152 2158
27. M.E. Steiner, N.S. Key, and J.H. Levy Activated recombinant factor VII in cardiac surgery Curr Opin Anaesthesiol 18 2005 89 92 (Pubitemid 40283854)
28. M. Levi, J.H. Levy, H.F. Andersen, and D. Truloff Safety of recombinant activated factor VII in randomized clinical trials N Engl J Med 363 2010 1791 1800
29. R. Gill, M. Herbertson, and A. Vuylsteke Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery Circulation 120 2009 21 27
30. R.M. Sniecinski, E.P. Chen, J.H. Levy, F. Szlam, and K.A. Tanaka Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa Anesth Analg 104 2007 763 765 (Pubitemid 46548293)
31. G. Despotis, M. Avidan, and D.M. Lublin Off-label use of recombinant factor VIIA concentrates after cardiac surgery Ann Thorac Surg 80 2005 3 5 (Pubitemid 40840172)
32. O. Godje, U. Gallmeier, M. Schelian, M. Grunewald, and H. Mair Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation Thorac Cardiovasc Surg 54 2006 26 33 (Pubitemid 43232140)
33. O. Godje, M. Haushofer, P. Lamm, and B. Reichart The effect of factor XIII on bleeding in coronary surgery Thorac Cardiovasc Surg 46 1998 263 267 (Pubitemid 28562035)
34. J.H. Levy, R. Gill, and N.A. Nussmeier Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer. A preliminary report Thromb Haemost 102 2009 765 771
35. J.H. Levy, K.A. Tanaka, and W. Dietrich Perioperative hemostatic management of patients treated with vitamin K antagonists Anesthesiology 109 2008 918 926
36. H.E. Achneck, B. Sileshi, R.M. Jamiolkowski, D.M. Albala, M.L. Shapiro, and J.H. Lawson A comprehensive review of topical hemostatic agents: efficacy and recommendations for use Ann Surg 251 2010 217 228
37. J.H. Lawson The clinical use and immunologic impact of thrombin in surgery Semin Thromb Hemost 32 Suppl 1 2006 98 110
38. J. Barnard, and R. Millner A review of topical hemostatic agents for use in cardiac surgery Ann Thorac Surg 88 2009 1377 1383